SEARCH RESULTS FOR: "Tag: OCUL"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(2)
2018(1)
2017(7)
2016(7)
2015(4)
CATEGORIES
Analyst Downgrades(1)
Analyst Upgrades(1)
Buzz Stocks(6)
Ezines(1)
General(3)
Intraday Option Activity(2)
Market Recap(1)
Midday Market Check(3)
Opening View(1)
Stock Market News(2)
Stocks On the Move(4)

6/21/2019 9:53 AM
The shares of Ocular Therapeutix Inc (NASDAQ:OCUL) are making a comeback today, after the drugmaker announced that the Food and Drug Administration (FDA) approved the company's DEXTENZA to treat pat...
5/21/2019 9:37 AM
Pharma stock Ocular Therapeutix Inc (NASDAQ:OCUL) is in hot water today, down 11% at $3.00 in early trading, and pacing for its worst day since Dec. 3. The stock is fresh off a new record low of $2.7...
6/29/2018 10:10 AM
Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) are down 2.2% at $7.09 in early trading, after the company announced its New Drug Application (NDA) resubmission for its eye pain drug DEXTENZA, to the ...
10/24/2017 3:51 PM
It's been a strong year for the biotech sector, with the SPDR S&P Biotech ETF (XBI) and Health Care Select Sector SPDR Fund (XLV) boasting year-to-date gains of 42% and 20%, respectively. Against this...
7/12/2017 10:08 AM
U.S. stocks are higher this morning, as markets prepare for Fed Chair Janet Yellen's remarks. Among specific stocks on the move today are biotech Ocular Therapeutix Inc (NASDAQ:OCUL), social media s...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center